Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis
- PMID: 29856752
- PMCID: PMC5983444
- DOI: 10.1371/journal.pone.0197540
Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis
Abstract
There are many challenges facing the use of alendronate sodium for the treatment of osteoporosis such as low bioavailability of 0.6% and oesophageal ulceration with bleeding. Due to the aforementioned limitation, the main objective of this research is to utilize a statistical experimental design in the formulation and optimization of alendronate in the form of controlled release biodegradable intramuscular in-situ gel. A Box-Behnken experimental design employing Statgraphics® software was used to develop an optimized in-situ gel formulation and to estimate the effects of Poly-DL-lactide-coglycolide as a primary polymer, the copolymer polycaprolactone, and lipid surfactant capryol 90. Every system was evaluated for gellation character, and in vitro release. As a novel technique for evaluation of the in-situ gel, in-vivo biodegradability rate was estimated in rats. Pharmacokinetic parameters were assessed in rabbits. The results indicated a significant effect of the copolymer and lipid surfactant on initial burst, and a significant effect of the primary and copolymer on drug percentage released. The optimum formulation showed a 5% initial burst, an in-vivo biodegradability rate estimated at 8% every seven days in rats, and the pharmacokinetic evaluation revealed that alendronate sodium mean residence time extended to 102 days in rabbits. In conclusion, the optimum biodegradable intramuscular in-situ gel formulations is a promising approach for providing higher bioavailability, extended release for more than three months, with elimination of esophageal side effects.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Alendronate Sodium as Enteric Coated Solid Lipid Nanoparticles; Preparation, Optimization, and In Vivo Evaluation to Enhance Its Oral Bioavailability.PLoS One. 2016 May 5;11(5):e0154926. doi: 10.1371/journal.pone.0154926. eCollection 2016. PLoS One. 2016. PMID: 27148747 Free PMC article.
-
Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.Drug Deliv. 2016 Nov;23(9):3712-3723. doi: 10.1080/10717544.2016.1223225. Epub 2016 Sep 30. Drug Deliv. 2016. PMID: 27689408
-
Synthesis, characterization and evaluation of tinidazole-loaded mPEG-PDLLA (10/90) in situ gel forming system for periodontitis treatment.Drug Deliv. 2016 Oct;23(8):2726-2735. doi: 10.3109/10717544.2015.1061069. Epub 2015 Aug 7. Drug Deliv. 2016. PMID: 26289210
-
Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.Drug Deliv. 2018 Nov;25(1):1340-1349. doi: 10.1080/10717544.2018.1477861. Drug Deliv. 2018. PMID: 29869516 Free PMC article.
-
Alendronate-loaded, biodegradable smart hydrogel: a promising injectable depot formulation for osteoporosis.J Drug Target. 2018 Aug;26(7):563-575. doi: 10.1080/1061186X.2017.1390670. Epub 2017 Oct 26. J Drug Target. 2018. PMID: 29073792
Cited by
-
Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control.Saudi Pharm J. 2023 Apr;31(4):499-509. doi: 10.1016/j.jsps.2023.02.002. Epub 2023 Feb 13. Saudi Pharm J. 2023. PMID: 37063437 Free PMC article.
-
Hydrogel-based delivery system applied in the local anti-osteoporotic bone defects.Front Bioeng Biotechnol. 2022 Nov 11;10:1058300. doi: 10.3389/fbioe.2022.1058300. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36440439 Free PMC article. Review.
-
Investigation of Alogliptin-Loaded In Situ Gel Implants by 23 Factorial Design with Glycemic Assessment in Rats.Pharmaceutics. 2022 Sep 5;14(9):1867. doi: 10.3390/pharmaceutics14091867. Pharmaceutics. 2022. PMID: 36145615 Free PMC article.
-
Rapid oral transmucosal delivery of zaleplon-lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation.Drug Deliv. 2022 Dec;29(1):2773-2783. doi: 10.1080/10717544.2022.2115165. Drug Deliv. 2022. PMID: 36036168 Free PMC article.
-
Self-Nanoemulsion Loaded with a Combination of Isotretinoin, an Anti-Acne Drug, and Quercetin: Preparation, Optimization, and In Vivo Assessment.Pharmaceutics. 2020 Dec 30;13(1):46. doi: 10.3390/pharmaceutics13010046. Pharmaceutics. 2020. PMID: 33396942 Free PMC article.
References
-
- Hosny KM, Osama A, Al-abdaly R. Enteric-coated alendronate sodium nanoliposomes: a novel formulations to overcome barriers for the treatment of osteoporosis. Expert Opinion on Drug Delivery 2013;10(6):741–6 doi: 10.1517/17425247.2013.799136 - DOI - PubMed
-
- Bone H G, Hosking D, Devogelaer J, Tucci J R, Emkey R D, Tonino R P, et al. Ten years' experience with alendronate for osteoporosis in postmenopausal women. New England Journal of Medicine, 2004;350:1189–99. doi: 10.1056/NEJMoa030897 - DOI - PubMed
-
- Schnitzer T, Bone H G, Crepaldi G, Adami S, McClung M, Kiel D, et al. Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Aging Clinical and Experimental Research, 2000:12;1–12. - PubMed
-
- Hosny KM. Alendronate Sodium as Enteric Coated Solid Lipid Nanoparticles; Preparation, Optimization, and In Vivo Evaluation to Enhance Its Oral Bioavailability. PLOS ONE 2016;11(5):e0154926 doi: 10.1371/journal.pone.0154926 - DOI - PMC - PubMed
-
- Peters ML, Leonard M, Licata AA. Role of Alendronate and Risedronate in Preventing and Treating Osteoporosis. Cleve Clin J Med 2001;68:945–51. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
